Retrospective validation of genomic biomarkers-- what are the questions, challenges and strategies for developing useful relationships to clinical outcomes-- workshop summary

Pharmacogenomics J. 2006 Mar-Apr;6(2):82-8. doi: 10.1038/sj.tpj.6500363.

Authors

S-J Wang¹, N Cohen, D A Katz, G Ruano, P M Shaw, B Spear

Affiliation

¹ Office of Biostatistics, Office of Pharmacoepidemiology and Statistical Science, Center for Drug Evaluation and Research, US FDA, Silver Spring, MD 20993, USA. [email protected]

PMID: 16402078
DOI: 10.1038/sj.tpj.6500363

No abstract available

Publication types

Consensus Development Conference

MeSH terms

Clinical Trials as Topic
Drug Design*
Drug Industry
Endpoint Determination
Genetic Markers*
Genomics*
Pharmacogenetics / methods*
Retrospective Studies
United States
United States Food and Drug Administration

Substances

Genetic Markers